Atria Investments Inc Sells 882 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Atria Investments Inc decreased its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 4.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 20,073 shares of the company’s stock after selling 882 shares during the period. Atria Investments Inc’s holdings in Bath & Body Works were worth $641,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Summit Global Investments raised its position in shares of Bath & Body Works by 57.4% in the 3rd quarter. Summit Global Investments now owns 15,783 shares of the company’s stock valued at $504,000 after buying an additional 5,753 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Bath & Body Works by 328.7% in the 3rd quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company’s stock valued at $34,153,000 after purchasing an additional 820,379 shares during the last quarter. Amalgamated Bank boosted its stake in shares of Bath & Body Works by 5.3% in the 3rd quarter. Amalgamated Bank now owns 70,060 shares of the company’s stock valued at $2,236,000 after purchasing an additional 3,553 shares during the last quarter. New York State Teachers Retirement System boosted its stake in shares of Bath & Body Works by 18.1% in the 3rd quarter. New York State Teachers Retirement System now owns 266,235 shares of the company’s stock valued at $8,498,000 after purchasing an additional 40,793 shares during the last quarter. Finally, Abich Financial Wealth Management LLC acquired a new position in shares of Bath & Body Works during the 3rd quarter valued at $103,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Down 3.2 %

Shares of BBWI opened at $30.45 on Wednesday. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The company has a 50 day moving average of $30.34 and a two-hundred day moving average of $36.18. The company has a market cap of $6.67 billion, a price-to-earnings ratio of 7.37, a price-to-earnings-growth ratio of 1.00 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. On average, sell-side analysts expect that Bath & Body Works, Inc. will post 3.18 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.63%. The ex-dividend date of this dividend is Friday, November 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

Analyst Ratings Changes

A number of research analysts recently issued reports on BBWI shares. Morgan Stanley dropped their target price on shares of Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a research report on Thursday, September 5th. Evercore ISI reduced their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research report on Wednesday, August 28th. The Goldman Sachs Group cut their target price on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. Citigroup cut their target price on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research report on Tuesday, August 20th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating for the company in a research report on Monday, August 26th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $42.44.

Insider Buying and Selling

In related news, CEO Gina Boswell bought 6,000 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.27% of the stock is owned by insiders.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.